相关实验视频
Updated: Mar 6, 2026

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
22.5K
[在俄罗斯联邦,在缺血性中风中使用特内克托普拉斯进行血栓溶解治疗的第一个经验]
N A Glotova1, R T Tairova1,2, N A Marskaya1
1Center of the Brain and Neurotechnologies, Moscow, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|March 5, 2026
概括
国内的薄膜甲 (Nektelisa) 在缺血性中风 (IS) 治疗方面显示出有前途的结果. 早期服用导致了显著的神经改善,三名患者没有出现重大并发症.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血栓溶解疗法 (TLT) 是缺血性中风 (IS) 的关键治疗方法.
- 丁氏甲是一种有效的纤维素分析剂,用于IS.
- 现在可以获得国内生产的基生物类似剂Nektelisa.
研究的目的:
- 报告Nektelisa在俄罗斯联邦首次使用TLT.
- 评估Nektelisa在IS患者的疗效和安全性.
主要方法:
- 三个IS患者接受Nektelisa的病例报告.
- 根据体重调整剂量.
- 神经成像在TLT前和24小时后进行.
主要成果:
- 在TLT后一小时内,神经缺陷的显著回归.
- 在24小时后没有观察到缺血区域的增加.
- 一例无症状下关节出血与快速再通道化;没有其他重大出血事件.
结论:
- 在治疗IS患者中,Nektelisa表现出高的疗效和安全性.
- 早期服用Nektelisa会导致神经系统的快速改善.
- 尼克特利萨代表了俄罗斯联邦IS的一个有价值的新疗法选择.
相关概念视频
Venous Thrombosis III: Interprofessional Care
428
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
428
Acute Coronary Syndrome IV: Interprofessional Care
356
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
356
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.1K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K

